Arena Pharmaceuticals, Inc. (ARNA) stock is up 32.37% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives ARNA stock a score of 62 out of a possible 100.
That rank is influenced by a long-term technical score of 95. ARNA's rank also includes a short-term technical score of 89. The fundamental score for ARNA is 3. In addition to the average rating from Wall Street analysts, ARNA stock has a mean target price of $93.88. This means analysts expect the stock to lose 5.97% over the next 12 months. ARNA has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on ARNA!